New
Global ETF Survey 2026: Answer now →
Help us improve your experience. Please confirm your investor type:
Global ETF Survey 2026
The ETF Industry Is Evolving Fast
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.
LFSC ETF · F/m Emerald Life Sciences Innovation ETF
The LFSC Exchange Traded Fund (ETF) is provided by Emerald Group. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update Today at 3:32 PM UTC
LIVE
CLOSED
This fund is part ofLife Sciences1M perf.+2.36%
Last price
$38.90
-0.46%
1M perf.
+1.03%
1M flows
+€45K
AuM
€90M
TER
0.79%
Rating
Not rated
ESG Consensus®
LFSC
$38.90
-0.46%
Performance & flows
Segment for quartile rank
March 4, 2026 → June 4, 2026
Create a free account to view the flows graph
LFSC
$39.06
+9.24%
Life Sciences
+9.24%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +1.03% | +9.24% | +62.94% | N/A | N/A | -0.85% | +11.53% | +6.69% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
6/4/2026
$39.06
1D NAV change
+2.68%
Dividend policy
No. of holdings
46
Inception date
10/31/2024
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The Fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust (the “Sub-Adviser”)
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
New to Trackinsight?
For individual investors
Essentials
A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors
Enterprise
Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trialSimilar ETFs in your region
ARKG
1M perf.
+18.53%
TER
0.75%
PSCH
1M perf.
+2.05%
TER
0.29%
CURE
1M perf.
+0.51%
TER
0.45%
XPH
1M perf.
-2.12%
TER
0.35%
XBI
1M perf.
-0.11%
TER
0.35%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +9.24% | +62.94% | N/A | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise
Exposure
Countries
USA
91.24%
United Kingdom
6.39%
Singapore
1.05%
Unavailable
1.32%
Sectors
Health Care
73.79%
Sovereign
1.39%
Unavailable
24.82%
Diversification
Total weight of top 15 holdings out of 46
Top 15 holdings
Data as of April 30, 2026
COGENT BIOSCIENCES
TRAVERE THERAPEUTICS INC
US00773J2024
LIVANOVA
MIRUM PHARMACEUTICALS INC
UTD THERAPEUT
US6402683063
KALVISTA PHARMACEUTICALS INC
Create a free account to view top holdings
GUARDANT HEALTH INC
BRIDGEBIO PHARMA
TRANSMEDICS GROUP
SAVARA INC
TREVI THERAPEUTICS
US9229671048
AXSOME THERA CMN STK
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise
Sustainability
Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise
Issuer
Emerald Group
Emerald Group ID Card
Number of funds
2
Total AuM
€116M
Expense ratio range
0.79% - 0.89%
Average expense ratio
0.84%
Top 2 funds by Emerald Group
| AuM | ||
|---|---|---|
LFSC | F/m Emerald Life Sciences Innovation ETF | €90M |
SPIT | F/m Emerald Special Situations ETF | €26M |
Frequently asked questions about LFSC
What does F/m Emerald Life Sciences Innovation ETF, LFSC, invest in?
LFSC is a Active ETF. This ETF provides exposure to Other Mid and Small-Cap Equities.
What is the Total Expense ratio (TER) of LFSC?
LFSC carries a total expense ratio (TER) of 0.79%, indicating the annual cost for holding the fund.
When was LFSC launched?
LFSC was introduced to the market on October 31, 2024. It trades on United States
Who is the ETF issuer of LFSC?
F/m Emerald Life Sciences Innovation ETF, LFSC, is provided by Emerald Group. Learn more about Emerald Group here.
What is the current assets under management (AUM) of LFSC?
LFSC oversees €90M in assets as of June 4, 2026.
How has LFSC performed lately?
Based on data from June 4, 2026, LFSC returned 1.03% over the past month, 9.24% over the last three months and 6.69% year-to-date.
What are the latest inflows or outflows for LFSC?
As of June 4, 2026, LFSC recorded net flows of +€34K over the last month and +€4.2M year-to-date.
Does LFSC distribute dividends?
LFSC follows a distributing dividend policy, meaning it pays out income to investors.
What are the main country or region exposures of LFSC?
As of April 30, 2026, LFSC has significant geographic allocations in USA, United Kingdom and Singapore.
In which sector or theme does LFSC invest in?
As of April 30, 2026, LFSC focuses largely on Health Care and Sovereign.
How many securities does LFSC hold and how diversified is it?
As of April 30, 2026, LFSC holds 46 positions in its portfolio, with 69.25% of assets concentrated in its top 15 holdings.
What are the main positions in LFSC?
As of April 30, 2026, LFSC top three holdings include COGENT BIOSCIENCES, TRAVERE THERAPEUTICS INC and US00773J2024.
What is the base currency of LFSC?
The base currency of LFSC is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
